311 related articles for article (PubMed ID: 34502425)
21. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
Loschiavo C; Grecò M; Polo A; Del Colle R
G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulatory therapies in neurologic critical care.
McDaneld LM; Fields JD; Bourdette DN; Bhardwaj A
Neurocrit Care; 2010 Feb; 12(1):132-43. PubMed ID: 19774497
[TBL] [Abstract][Full Text] [Related]
23. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
24. [High doses of immunoglobulin G in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome].
Lavrnić D; Romić M; Kacar A; Stojanović-Rakocević V; Stević Z; Vujić A; Basta I; Marjanović I; Bogdanović G; Apostolski S
Vojnosanit Pregl; 2006 Jan; 63(1):37-42. PubMed ID: 16471247
[TBL] [Abstract][Full Text] [Related]
25. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora.
Yokote H; Miyake S; Croxford JL; Oki S; Mizusawa H; Yamamura T
Am J Pathol; 2008 Dec; 173(6):1714-23. PubMed ID: 18974295
[TBL] [Abstract][Full Text] [Related]
26. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
Parekh VV; Wu L; Olivares-Villagómez D; Wilson KT; Van Kaer L
J Immunol; 2013 Mar; 190(5):1948-60. PubMed ID: 23345328
[TBL] [Abstract][Full Text] [Related]
27. Invariant natural killer T cells and their ligands: focus on multiple sclerosis.
O'Keeffe J; Podbielska M; Hogan EL
Immunology; 2015 Aug; 145(4):468-75. PubMed ID: 25976210
[TBL] [Abstract][Full Text] [Related]
28. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
Gigli G; Caielli S; Cutuli D; Falcone M
Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune mediated neuromuscular junction defects.
Farrugia ME; Vincent A
Curr Opin Neurol; 2010 Oct; 23(5):489-95. PubMed ID: 20651592
[TBL] [Abstract][Full Text] [Related]
30. The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosis.
Roozbeh M; Mohammadpour H; Azizi G; Ghobadzadeh S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):105-13. PubMed ID: 24601677
[TBL] [Abstract][Full Text] [Related]
31. Myasthenia gravis and related disorders: Pathology and molecular pathogenesis.
Ha JC; Richman DP
Biochim Biophys Acta; 2015 Apr; 1852(4):651-7. PubMed ID: 25486268
[TBL] [Abstract][Full Text] [Related]
32. Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis.
Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Itoyama Y
J Neuroimmunol; 2005 Oct; 167(1-2):186-9. PubMed ID: 16040133
[TBL] [Abstract][Full Text] [Related]
33. Cold reactive antilymphocyte antibodies in neurological diseases.
Lisak RP; Mercado F; Zweiman B
J Neurol Neurosurg Psychiatry; 1979 Nov; 42(11):1054-7. PubMed ID: 315450
[TBL] [Abstract][Full Text] [Related]
34. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.
Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K
Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708
[TBL] [Abstract][Full Text] [Related]
35. Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barré syndrome as well as their animal models.
Wang X; Ma C; Wu J; Zhu J
J Neurosci Res; 2013 Jul; 91(7):871-81. PubMed ID: 23653308
[TBL] [Abstract][Full Text] [Related]
36. Immune regulation by invariant NKT cells in autoimmunity.
Ronchi F; Falcone M
Front Biosci; 2008 May; 13():4827-37. PubMed ID: 18508548
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic strategy for multiple sclerosis targeting NK and NKT cells].
Yamamura T
Rinsho Shinkeigaku; 2001 Dec; 41(12):1162-4. PubMed ID: 12235827
[TBL] [Abstract][Full Text] [Related]
38. The role of invariant NKT cells in organ-specific autoimmunity.
Di Pietro C; Falcone M
Front Biosci (Landmark Ed); 2014 Jun; 19(8):1240-50. PubMed ID: 24896348
[TBL] [Abstract][Full Text] [Related]
39. Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
Van Kaer L; Wu L; Parekh VV
Immunology; 2015 Sep; 146(1):1-10. PubMed ID: 26032048
[TBL] [Abstract][Full Text] [Related]
40. Haemophilus influenzae infection and Guillain-Barré syndrome.
Mori M; Kuwabara S; Miyake M; Noda M; Kuroki H; Kanno H; Ogawara K; Hattori T
Brain; 2000 Oct; 123 ( Pt 10)():2171-8. PubMed ID: 11004133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
